HHS Supporting Clinical Study of Zika Virus Blood Screening Test

"BARDA staff has worked closely with our partners at FDA and the Office of the Assistant Secretary of Health to ensure the continuity and safety of the U.S. blood supply," said Dr. Richard Hatchett, BARDA's acting director. "Today's award to Roche is an important step towards securing the safety of the blood supply in Puerto Rico and in the rest of the United States."

The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) and the Office of the Assistant Secretary for Health are supporting the development of a test to identify whether donated blood is infected with the Zika virus, HHS announced April 22, reporting that ASPR's Biomedical Advanced Research and Development Authority, known as BARDA, agreed that day to support a clinical study to evaluate the sensitivity and specificity of the blood donation screening test in its actual use. This study is necessary to apply for FDA approval for commercial marketing.

The test is manufactured by Roche Molecular Systems, Inc., which is based in Branchburg, N.J.

"BARDA staff has worked closely with our partners at FDA and the Office of the Assistant Secretary of Health to ensure the continuity and safety of the U.S. blood supply," said Dr. Richard Hatchett, BARDA's acting director. "Today's award to Roche is an important step towards securing the safety of the blood supply in Puerto Rico and in the rest of the United States."

According to HHS, most people infected with Zika do not have symptoms and may donate blood not knowing that they are infected. And there have been reports of probable cases of transfusion transmission of Zika virus in Brazil that are being investigated. So having an accurate blood donation screening test will help to ensure that infected blood is removed from the blood supply.

Under a one-year, $354,500 contract, Roche will study blood samples to confirm whether the test accurately and reliably detects and identifies Zika virus, even when present in a very low concentration in a donor's blood.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2022

    June 2022

    Featuring:

    • SAFETY CULTURE
      Corporate Safety Culture Is Workplace Culture
    • HEAT STRESS
      Keeping Workers Safe from Heat-Related Illnesses & Injuries
    • EMPLOYEE HEALTH SCREENING
      Should Employers Consider Oral Fluid Drug Testing?
    • PPE FOR WOMEN
      Addressing Physical Differences
    View This Issue